Literature DB >> 6469482

Primary aldosteronism associated with chronic renal failure. Report of a case.

T Nakada, M Kimura.   

Abstract

An aldosterone-producing adenoma (APA) was associated with chronic renal failure. Following treatment with Trilostane (a 3 beta-hydroxysteroid dehydrogenase inhibitor), furosemide and continuous ambulatory peritoneal dialysis (CAPD), a left adrenal adenoma was successfully removed. This patient, still being treated with CAPD, is a unique example of primary aldosteronism without showing suppressed plasma renin activity.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6469482     DOI： 10.1007/bf02082781

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  11 in total

Review 1.  Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure.

Authors:  H Gavras; J A Oliver; P J Cannon
Journal:  Annu Rev Med       Date:  1976       Impact factor: 13.739

2.  Trilostane interference with steroid assays.

Authors:  G H Beastall; W A Ratcliffe; M Thomson; C G Semple
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

3.  Remission or recurrent hyperaldosteronism resulting from subtotal adrenalectomy of adenomatous hyperplastic adrenal glands.

Authors:  T Kawasaki; T Omae; K Tanaka; M Matsunage; K Emoto
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

4.  Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism.

Authors:  J B Ferriss; D G Beevers; J J Brown; D L Davies; R Fraser; A F Lever; P Mason; A M Neville; J I Robertson
Journal:  Am Heart J       Date:  1978-03       Impact factor: 4.749

5.  [A case of primary aldosteronism with chronic renal failure (author's transl)].

Authors:  M Obana; Y Hayakawa; F Higashi; S Irimajiri; I Fujimori; T Suito; T Saito; J Fukuda; K Kondo; T Saruta; E Kato
Journal:  Nihon Jinzo Gakkai Shi       Date:  1980-01

6.  Continuous ambulatory peritoneal dialysis. Council on Scientific Affairs.

Authors: 
Journal:  JAMA       Date:  1982-11-12       Impact factor: 56.272

7.  Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.

Authors:  P Komanicky; R F Spark; J C Melby
Journal:  J Clin Endocrinol Metab       Date:  1978-11       Impact factor: 5.958

8.  The juxtaglomerular complex.

Authors:  P M Hartroft
Journal:  Annu Rev Med       Date:  1966       Impact factor: 13.739

9.  Trilostane, an orally active inhibitor of steroid biosynthesis.

Authors:  G O Potts; J E Creange; H R Hardomg; H P Schane
Journal:  Steroids       Date:  1978-09       Impact factor: 2.668

10.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391
View more
  5 in total

1.  A case of primary aldosteronism with end stage renal disease.

Authors:  Hyun Hee Na; Kyung Jun Park; Sun Young Kim; Haeng Il Koh
Journal:  Electrolyte Blood Press       Date:  2006-11

2.  Complete remission of hypertension in a hemodialysis patient after adrenalectomy for primary aldosteronism and renal transplantation.

Authors:  Daisuke Watanabe; Satoshi Morimoto; Noriyoshi Takano; Shihori Kimura; Yasufumi Seki; Kanako Bokuda; Midori Sasaki-Yatabe; Junichi Yatabe; Hiromi Onizuka; Tomoko Yamamoto; Takashi Ando; Atsuhiro Ichihara
Journal:  CEN Case Rep       Date:  2017-12-29

Review 3.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Authors:  Hiroyuki Koshiyama; Takeshi Fujisawa; Naomitsu Kuwamura; Yoshio Nakamura; Hiroshi Kanamori; Emi Oida; Akira Hara; Takashi Suzuki; Hironobu Sasano
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

4.  Therapeutic results of primary aldosteronism with special reference to renal or renovascular lesions.

Authors:  T Nakada; H Koike; T Akiya; T Katayama; M Takata; H Iida; Y Mizumura
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

5.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.